KIMS

Krishna Institute of Medical Sciences Limited

Hyderabad-based multi-specialty hospital chain — tertiary and quaternary care

Healthcare›Healthcare›Healthcare Services›Hospital

kimshospitals.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹685.60
Market cap
28,795 Cr
Stock P/E
140.8
P/B
12.23
Dividend yield
0.7%
ROE (FY26)
9.4%
ROCE (FY26)
9.2%
Operating margin (FY26)
13.3%
Debt / equity (FY26)
1.44
OCF / EBITDA (FY26)
63.7%
OCF / EBITDA (3Y)
72.5%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

KIMS (Krishna Institute of Medical Sciences) runs a chain of multi-specialty hospitals in Telangana, Andhra Pradesh, Karnataka, Kerala and Maharashtra.

Company snapshot

8thBy market cap

Ranked among 24 companies in Hospital.

What we see

Positives
  • ✓Dividend payout of 86% — the company returns a meaningful share of profits to shareholders.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales652 Cr606 Cr634 Cr688 Cr777 Cr772 Cr797 Cr872 Cr961 Cr998 Cr1,075 Cr1,180 Cr
Operating expenses (approx.)475 Cr459 Cr475 Cr509 Cr559 Cr585 Cr599 Cr679 Cr757 Cr799 Cr868 Cr956 Cr
EBITDA177 Cr147 Cr159 Cr179 Cr218 Cr187 Cr198 Cr193 Cr204 Cr199 Cr207 Cr223 Cr
OPM %27.2%24.3%25.1%26.1%28.1%24.2%24.8%22.1%21.2%19.9%19.2%18.9%
Other income3 Cr3 Cr4 Cr5 Cr5 Cr18 Cr5 Cr7 Cr4 Cr5 Cr10 Cr16 Cr
Interest9 Cr12 Cr16 Cr18 Cr20 Cr26 Cr27 Cr33 Cr45 Cr57 Cr68 Cr83 Cr
Depreciation33 Cr35 Cr46 Cr39 Cr41 Cr45 Cr53 Cr53 Cr66 Cr79 Cr85 Cr101 Cr
Profit before tax139 Cr102 Cr100 Cr127 Cr162 Cr135 Cr134 Cr114 Cr97 Cr69 Cr55 Cr57 Cr
Tax %26.9%25.3%28.5%25.1%25.6%31.3%20.8%25.2%25.6%24.3%39.6%33.9%
Net profit101 Cr77 Cr71 Cr95 Cr121 Cr93 Cr106 Cr85 Cr72 Cr52 Cr33 Cr37 Cr
EPS (₹)₹11.50₹8.98₹8.18₹10.82₹2.68₹2.22₹2.54₹1.96₹1.67₹1.33₹1.06₹1.04

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales918 Cr1,123 Cr1,330 Cr1,651 Cr2,198 Cr2,498 Cr3,035 Cr3,905 CrSign in free for the trailing twelve months
Operating expenses (approx.)837 Cr878 Cr959 Cr1,135 Cr1,594 Cr1,858 Cr2,252 Cr3,103 CrSign in free for the trailing twelve months
EBITDA81 Cr245 Cr371 Cr516 Cr604 Cr640 Cr783 Cr802 CrSign in free for the trailing twelve months
OPM %8.8%21.8%27.9%31.2%27.5%25.6%25.8%20.5%Sign in free for the trailing twelve months
Other income6 Cr6 Cr10 Cr20 Cr26 Cr13 Cr32 Cr26 CrSign in free for the trailing twelve months
Interest46 Cr40 Cr32 Cr16 Cr31 Cr47 Cr90 Cr203 CrSign in free for the trailing twelve months
Depreciation56 Cr71 Cr70 Cr73 Cr129 Cr147 Cr177 Cr283 CrSign in free for the trailing twelve months
Profit before tax-15 Cr141 Cr279 Cr458 Cr485 Cr460 Cr558 Cr334 CrSign in free for the trailing twelve months
Tax %-217.3%18.1%26.4%25.0%24.6%26.9%25.7%27.5%Sign in free for the trailing twelve months
Net profit-49 Cr115 Cr205 Cr344 Cr366 Cr336 Cr415 Cr242 CrSign in free for the trailing twelve months
EPS (₹)₹-6.91₹16.00₹26.87₹41.88₹42.03₹38.75₹9.61₹6.03Sign in free for the trailing twelve months
Dividend payout %———0.0%0.0%0.0%0.0%85.6%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital74 Cr74 Cr78 Cr80 Cr80 Cr80 Cr80 Cr80 Cr
Reserves466 Cr524 Cr786 Cr1,307 Cr1,590 Cr1,748 Cr2,058 Cr2,167 Cr
Borrowings260 Cr279 Cr240 Cr161 Cr678 Cr1,355 Cr2,557 Cr3,244 Cr
Other liabilities293 Cr306 Cr320 Cr336 Cr325 Cr403 Cr761 Cr1,956 Cr
Total liabilities1,120 Cr1,196 Cr1,436 Cr1,907 Cr2,941 Cr3,852 Cr5,736 Cr7,759 Cr
Fixed assets (net)708 Cr749 Cr771 Cr771 Cr1,381 Cr1,730 Cr2,199 Cr4,186 Cr
CWIP0.23 Cr2 Cr9 Cr21 Cr477 Cr600 Cr1,214 Cr606 Cr
Investments——51 Cr332 Cr68 Cr157 Cr99 Cr16 Cr
Loans & advances——2 Cr0 Cr0 Cr0 Cr48 Cr72 Cr
Inventories27 Cr30 Cr24 Cr36 Cr43 Cr49 Cr64 Cr97 Cr
Trade receivables123 Cr132 Cr110 Cr129 Cr253 Cr294 Cr395 Cr554 Cr
Cash & bank8 Cr41 Cr52 Cr26 Cr62 Cr47 Cr56 Cr55 Cr
Other assets253 Cr242 Cr417 Cr593 Cr659 Cr974 Cr1,661 Cr2,172 Cr
Total assets1,120 Cr1,196 Cr1,436 Cr1,907 Cr2,941 Cr3,852 Cr5,736 Cr7,759 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity134 Cr202 Cr—520 Cr432 Cr521 Cr582 Cr511 Cr
Cash from investing-110 Cr-125 Cr—-606 Cr-616 Cr-753 Cr-1,116 Cr-1,452 Cr
Cash from financing-27 Cr-44 Cr—60 Cr88 Cr217 Cr543 Cr940 Cr
Net cash flow-3 Cr32 Cr—-26 Cr-95 Cr-15 Cr9 Cr-0.60 Cr
Free cash flow (OCF − Capex)57 Cr150 Cr—350 Cr-142 Cr-126 Cr-427 Cr-917 Cr

Ratios

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %3.7%20.3%27.9%30.2%19.7%14.7%13.0%9.2%
ROE %-8.4%19.5%23.0%23.6%17.4%14.8%15.9%9.4%
Debtor days4943302842434752
Inventory days11103187789
Days payable41401702929293230
Cash conversion cycle1813-109820212331
OCF / EBITDA %165.4%82.2%—100.8%71.5%81.4%74.3%63.7%
OCF / EBITDA % (3 years)—————83.7%75.7%72.5%
Debt / equity0.480.470.280.120.410.741.201.44
Current ratio0.871.001.621.831.611.310.830.76
Net debt / EBITDA3.120.970.510.261.022.043.193.98